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Needle exchanges are key to reducing transmission of bloodborne viruses (BBVs) in injecting drug
users (IDUs) through the provision of sterile injecting equipment and related interventions [1]. In
the United Kingdom (UK), the extent and type of service provision by needle exchanges has
received little attention [2]. Information on the availability, use and coverage of harm reduction
measures for IDUs is needed to help assess the effectiveness of existing, and inform the
development of future, services [3]. A national survey of needle exchange facilities was
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undertaken in 2005, and reports of the findings from Scotland have recently been released
Scottish Executive [4]. The National Treatment Agency for Substance Misuse (NTA) has released
summary finding from England and will shortly be publishing a report on the full findings [5];
results for Wales and Northern Ireland are not yet available.
The survey was initiated in response to the Department of Health’s 2004 Hepatitis C Action Plan
for England [6], and examined the extent, nature, and commissioning of needle exchange
provision in the UK. Three postal questionnaires and three focus groups were used to collect
quantitative and qualitative data from pharmacy exchange coordinators, non-pharmacy needle
exchange providers and drug action team (DAT) coordinators, commissioning managers or their
equivalents. Each country is split into DAT regions (149 in England and 22 in Scotland), which are
partnerships responsible for overseeing and commissioning drug services at a local level. There
was a good overall response rate, but incomplete questionnaires meant that some questions had
a much lower response rate.
The survey identified 188 needle exchange facilities in Scotland, and at least 1326 in England;
the total number of facilities in England could not be ascertained due to the lack of response
from around a quarter of the DATs. Pharmacies made up 80% of services for which responses
were received in England and 72% in Scotland. The remainder were specialist services, some of
which were mobile or outreach in nature. There were only a small number of exchanges based in
police custody facilities and hospital accident and emergency departments. Although there are
benefits to having different types of services, both reports noted that pharmacy services should
be developed to complement specialist services rather than as an alternative.
A low number of responses to questions on the distribution of injecting equipment made it
difficult to estimate the national levels of needle and syringe provision. Overall, data suggested
that ‘on average, clients of specialist needle exchange services and pharmacy schemes were
given the equivalent of approximately one syringe for every two days’ [4]. Although pharmacies
made up the majority of needle exchange facilities in both England and Scotland, approximately
half of all syringe distribution was through pharmacy exchanges and half through non-pharmacy
exchanges, with a notable variation in the amount distributed in different regions within both
countries.
There was geographical variation in the types of injecting related equipment provided by
services. The majority of services provided swabs, sharps bins and citric acid. English services
were more likely to distribute filters, sterile water and vitamin C, while Scottish services were
more likely to distribute wipes or swabs. There was also geographical variation in the provision of
BBV interventions. For example, almost 80% of specialist services in northwest England reported
offering hepatitis C testing, compared with under 20% in the southwest. Half of the specialist
services in England offered on-site hepatitis B vaccination, compared with only 29% in Scotland.
English centres were more likely to offer other BBV interventions such as testing for HIV,
hepatitis C or hepatitis B (Table). However, data were not collected on the uptake of BBV
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interventions and therefore it was not possible to assess the extent of BBV testing or
vaccination at these services.
Table. Proportion of specialist needle exchanges offering bloodborne virus interventions in
England and Scotland.
Bloodborne virus
intervention
Proportion of exchanges providing
service
England Scotland
Hepatitis A vaccination 25% 16%
Hepatitis B vaccination 50% 29%
HIV testing 31% 29%
Tetanus vaccine 11% 2%
Hepatitis C testing 43% 40%
Hepatitis B testing 42% 33%
A recurring theme in both reports was the inconsistency in services provided by needle
exchanges. The English report concluded that ‘what interventions injectors received was often
not determined by their needs but by where they lived’.[5]
Transmission of BBVs among IDUs continues to be a problem in the UK [7]. It is important that
needle exchanges are developed to deliver a range of services to clients, including the provision
of sufficient sterile injecting equipment and other BBV interventions (such as vaccination,
testing, counselling and awareness raising), and that the effectiveness of these services at
preventing the spread of BBVs among IDUs are also evaluated. The reports from Scotland and
England make a number of recommendations to develop standards for needle exchange services,
including guidelines for paraphernalia (drug taking equipment) distribution.
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